Interferon Beta Use by Pregnant and Breastfeeding Patients OK, Office in Europe Says
If necessary, women with relapsing multiple sclerosis can continue treatments based on interferon beta while pregnant and breastfeeding, according to…
Articles by Marisa Wexler, MS
EMD Serono Opening Phase 3 Trials of Oral Evobrutinib in Relapsing MS Patients
EMD Serono (Merck KGaA in Germany) is opening two pivotal and global Phase 3 clinical trials to evaluate the…
FTC Warns Companies Against Unsubstantiated Advertising of CBD Products for MS
The U.S. Federal Trade Commission (FTC) sent warning letters to three companies that sell cannabis-based products containing cannabidiol…
New AAN Guidelines Favor Regular Vaccinations, Including Flu Shots, for MS Patients
New guidelines from the American Academy of Neurology (AAN) recommend that people with multiple sclerosis (MS) keep up with…
Phase 1 Clinical Trial of EHP-101 Concludes with Positive Safety Results
The first in-human clinical trial of EHP-101, an investigational treatment for multiple sclerosis (MS) and systemic scleroderma (SSc),…
Imaging That Captures Damage to Brain in CIS Helps in Determining Likelihood of MS, Study Says
Imaging techniques that measure damage to the brain, in addition to those that detect lesions, may be useful in predicting…
NHS ‘Toolkit’ Aims to Improve Care Given People with MS, Other Neurological Ills in UK
The National Health Service (NHS) England announced an initiative that aims to speed diagnoses and ensure better all-around care for…
MS Therapies Among Limited Offerings Through AllianceRx Walgreens Prime
Medications for treating certain rare and chronic conditions, Â including multiple sclerosis (MS), are now available from the specialty and home…
Study Shows Range of Psychological and Physical Problems in Opioid-addicted MS Patients
Opioid addiction increases the risk for a number of physical and psychological problems in people with multiple sclerosis (MS), a…
Smartphones Could Be Used to Make Tremor Research Easier, More Affordable, Study Finds
Smartphones could be used as an inexpensive and effective way to measure  tremors in mice, which may allow for more…
Music While Walking Makes MS Patients More Motivated and Less Mentally Drained, Study Suggests
People listening to music during an extended walk tend to sync their steps to its beat — and for those with…
Antiviral and Nausea Treatments Ease Fatigue in MS, Small Study Reports
An antiviral medication called amantadine and ondansetron, which treats chronic nausea, both work to reduce fatigue in people with…
Convelo Therapeutics and Genentech Join Forces to Develop Remyelination Therapies
Convelo Therapeutics has announced a collaboration with Genentech, a member of the…
Independent Mouse Study Reinforces Remyelinating Potential of ISP Therapy
A new study demonstrates that intracellular sigma peptide (ISP) can promote remyelination in a mouse model of multiple sclerosis…
New Jersey Health Foundation Awards $70,000 to Kessler Foundation Researchers Studying MS and Stroke
Two researchers at Kessler Foundation were awarded grants of $35,000 each by the…
Blocking Sortilin Protein May Be Potential Treatment for Chronic Nerve Pain, Mouse Study Suggests
Inhibiting the function of a protein called sortilin — an important regulator of nerve damage-induced pain in mice —…
Potential Mechanism Behind Effectiveness of B-cell Depletion Therapy in MS Uncovered
The loss of immune B-cells, and the resulting changes in the profile of immune T-cells, is a major mechanism of…
Childhood MS Linked to Greater Cognitive Impairment in Adulthood, Study Finds
People with pediatric-onset multiple sclerosis (POMS) have a greater decline in cognitive function, and are more likely to experience…
Elevated Blood Pressure May Predict Brain Bleeding in RRMS Patients Treated with Lemtrada, Study Suggests
New research suggests that rising blood pressure might be predictive of intracranial hemorrhage — bleeding in the brain, a serious…
Biotech Startup Receives Funding to Pursue Cell-based Therapies for Neurological Disorders
Startup company Oscine Therapeutics has received an investment from Sana Biotechnology to support the research and development of…
Study Identifies Possible Genetic Causes of MS
Scientists are zeroing in on mutations in a few genes that appear to be major risk factors for developing multiple…
Roche, Sutter Health Testing Floodlight Mobile App That Monitors Patients’ MS
Sutter Health, a California-based healthcare group, has partnered with the biotechnology company Roche to test a new mobile…
Celgene and MS Association of America Collaborating to Boost Knowledge on Brain Health in MS
Biopharmaceutical company Celgene has teamed up with the Multiple Sclerosis Association of America (MSAA) to launch a new…
#AANAM — Evobrutinib Continues to Show Potential for MS, 48-week Phase 2 Data Suggest
Investigational therapy evobrutinib, also known as M2951, can reduce relapse rates and brain lesions in people with relapsing forms of…
#AANAM — Gut Bacteria May Play Role in Pediatric MS, Studies Suggest
As strange as it is to think about, many bacteria live in the human body, most of which…
#AANAM – Biogen Offers Update on Development Plans for MS Therapies
At the 2019 annual meeting of the American Academy of Neurology (AAN), Multiple Sclerosis News Today sat down with Bernd Kieseier,…
#AANAM – Ocrevus Effective in RRMS Patients with Poor Responses to Other DMTs, Early Trial Data Suggest
Early, one-year data from the Phase 3 CHORDS study show that Ocrevus effectively prevents relapses and disease progression in relapsing-remitting multiple…
#AANAM – Interferon Beta Exposure Does Not Seem to Increase Risk of Pregnancy Complications, Study Suggests
Exposure to interferon beta does not seem to increase the risk of complications during pregnancy in women with multiple…
#AANAM – Research Suggests Extended Interval Dosing of Tysabri Can Decrease Risk of PML
New data suggests that treatment with Tysabri (natalizumab) in an extended interval dosing regimen is associated with a significantly lower risk…
#AANAM – Research Suggests Misconceptions About MS Risk in Pregnant Women
New research suggests that even though pregnant women with multiple sclerosis (MS) are often viewed as high risk by…